Your browser doesn't support javascript.
loading
The Relationship of Preconception and Early Pregnancy Isoprostanes with Fecundability and Pregnancy Loss.
Nobles, Carrie J; Mendola, Pauline; Mumford, Sunni L; Silver, Robert M; Kim, Keewan; Perkins, Neil J; Schisterman, Enrique F.
Afiliação
  • Nobles CJ; From the Department of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA.
  • Mendola P; Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY.
  • Mumford SL; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.
  • Silver RM; Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT.
  • Kim K; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD.
  • Perkins NJ; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD.
  • Schisterman EF; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.
Epidemiology ; 34(5): 759-766, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37255247
ABSTRACT

BACKGROUND:

Although redox stress likely plays an important role in reproductive health, the utility of peripheral biomarkers of oxidative stress, such as isoprostanes, during the periconception period remains underexplored. We evaluated the relationship between isoprostanes during preconception and gestational week 4 and women's reproductive health outcomes.

METHODS:

The Effects of Aspirin in Gestation and Reproduction trial (2007-2011) enrolled 1228 women attempting pregnancy and followed them for up to 6 menstrual cycles and throughout pregnancy if they became pregnant. We measured creatinine-adjusted, log-transformed isoprostanes 8-iso-prostaglandin F 2α (8-iso-PGF2α), its metabolite 2,3-dinor-iPF2α-III, and stereoisomers 5-iso-PGF2α-VI and 8,12-iso-iPF2α-VI in urine during preconception and 4 weeks gestation. We evaluated pregnancy among participants in each menstrual cycle using human chorionic gonadotropin (hCG) and defined pregnancy loss as observed loss following positive hCG. We calculated fecundability odds ratios (FOR) and 95% confidence intervals (CI) using discrete-time Cox proportional hazards models and relative risk of pregnancy loss using adjusted log-binomial models.

RESULTS:

Higher preconception isoprostane levels were associated with lower fecundability [e.g., FOR = 0.89; 95% CI = 0.81, 0.97 per interquartile range (IQR) increase in 8-iso-PGF2α]. Among 797 pregnancies, isoprostane levels increased from preconception to 4 weeks gestation (e.g., mean difference = 0.12; 95% CI = 0.10, 0.14 ng/mL for 8-iso-PGF2α) and higher isoprostanes at 4 weeks gestation were associated with lower risk of pregnancy loss (e.g., RR = 0.79; 95% CI = 0.62, 1.00 per IQR increase in 8-iso-PGF2α).

CONCLUSIONS:

Preconception urinary isoprostanes may identify redox stress pathways associated with lower fecundability. However, the increase in isoprostanes into gestational week 4 and the associated lower risk of pregnancy loss may suggest confounding by latent factors in early pregnancy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aborto Espontâneo / Isoprostanos Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Epidemiology Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aborto Espontâneo / Isoprostanos Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Epidemiology Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos